Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,012,817
-$1,188,035 QoQ
Shares Held
125,117
-16.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#792
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simmons Bank holds $67,934,657 across 11 Drug Manufacturers - General names. PFE ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
51,844 | $13,046,023 | |
| 2 | LLY |
ELI LILLY & Co
|
10,864 | $13,030,606 | |
| 3 | AMGN |
Amgen Inc
|
26,161 | $9,473,419 | |
| 4 | MRK |
Merck & Co., Inc.
|
70,419 | $9,048,841 | |
| 5 | JNJ |
Johnson & Johnson
|
35,136 | $8,923,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,464 | $4,733,201 | |
| 7 | PFE |
Pfizer Inc
This page
|
125,117 | $3,012,817 | |
| 8 | GSK |
GSK plc
|
57,449 | $3,011,475 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,012,817 | 125,117 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,200,852 | 149,603 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,687,341 | 148,086 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,780,416 | 148,368 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,742,486 | 154,393 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,968,928 | 156,627 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,301,839 | 162,150 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5,010,728 | 173,142 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $5,041,798 | 180,193 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $5,292,257 | 190,712 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,988,648 | 277,480 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,035,838 | 272,410 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $9,945,780 | 271,150 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $10,317,788 | 252,887 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $12,628,660 | 246,461 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $10,586,287 | 241,917 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $12,890,229 | 245,856 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $12,369,249 | 238,927 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $14,036,716 | 237,709 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $10,411,215 | 242,065 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $9,257,775 | 236,409 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $8,546,620 | 235,899 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $9,146,806 | 248,487 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $9,114,689 | 248,357 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,279,221 | 253,187 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,939,633 | 243,249 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||